Brain implants, made from small clusters of brain cells, could help restore neural pathways damaged by Parkinson’s disease.

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

Veterans diagnosed with post-traumatic stress disorder may experience thrashing sleep, which can lead to more extensive ...

Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing ...

New research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other ...

Our lab has been trying to better illuminate this 'gut-first' pathway of Parkinson’s disease because it can open new avenues for early intervention and treatment strategies," said corresponding author ...